May 14, 2015Open Access

Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD

Key Points

Key points are not available for this paper at this time.

Abstract

The GA-map Dysbiosis Test identifies and characterises dysbiosis in IBS and IBD patients, and provides insight into a patient's intestinal microbiota. Evaluating microbiota as a diagnostic strategy may allow monitoring of prescribed treatment regimens and improvement in new therapeutic approaches.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Casèn et al. (Thu,) studied this question.

synapsesocial.com/papers/69dff697ca6b6a26158606d1 https://doi.org/https://doi.org/10.1111/apt.13236

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Methodology and Indications of H<sub>2</sub>‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference2009 · 442 citations
250-50 multivariate analysis of variance for collinear responses2002 · 128 citations
3Sa1245 Gut Microbiota in IBD Patients With IBS Before and After 6 Weeks of Low FODMAP Diet2014 · 4 citations
4Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis2009 · 351 citations
5Pyrosequencing study of fecal microflora of autistic and control children2010 · 967 citations

Bookmark

View Full Paper